Voluntary License Agreements for Generic Manufacturers: are they an effective path towards improving access to medicines in developing countries?

Código de los documentosSCP/29/U SHARING SESSION ON LICENSING/ERNESTO CAVELIER
Reuniones conexosSCP/29
Fecha de publicación11 de diciembre de 2018
EnglishVoluntary License Agreements for Generic Manufacturers: are they an effective path towards improving access to medicines in developing countries?
Documento completo
Voluntary License Agreements for Generic Manufacturers: are they an effective path towards improving access to medicines in developing countries?, single (pdf)
828 KB
https://www3.wipo.int/contact/es/area.jsp?area=meetings https://www.wipo.int/pressroom/es/ https://www.wipo.int/tools/es/disclaim.html https://www.wipo.int/tools/es/privacy_policy.html https://www.wipo.int/accessibility/es/ https://www.wipo.int/tools/es/sitemap.html https://www3.wipo.int/newsletters/es/ https://www.wipo.int/podcasts/es/ https://www.wipo.int/news/es/